Did you suffer a heart attack after undergoing kidney dialysis, or did someone you love die from cardiac arrest after undergoing kidney dialysis? If you can answer in the affirmative for either question, you may have a case. Contact the office of Frank Charles Miranda, P.A. today for a free evaluation of your kidney dialysis cardiac case.
The Serious Effects Suffered After Hemodialysis
There are roughly 400,000 cases of renal failure (kidney failure) in the United States, meaning that these people are unable to filter and remove the wastes from their own blood. These patients must undergo dialysis regularly, using a machine that cleanses the blood in place of the failing kidneys. Hemodialysis treatments use concentrates that contain acetate, acetic acid or citrate to filter and remove wastes from the blood. More than thirty percent of these patients received treatment using solutions called GranuFlo or NaturaLyte, before these concentrates were recalled by the Food and Drug Administration (FDA).
Dialysis patients who received treatments using either GranuFlo or NaturaLyte were reported to be up to 5 times more at risk to suffer cardiac arrest. The Food and Drug Administration issued Class 1 recalls, the most serious, on the two products in June 2012. Hemodialysis patients or their surviving family members are currently filing cases for suffering heart attacks, and hear related problems within twenty-four hours of undergoing dialysis treatment between 2008 and 2012. Evidence indicates that the manufacturer was aware of nearly 1,000 reports of cardiac arrest in 2012, may have known potential additional risks and did not alert patients until an internal memo from the manufacturer hit the FDA radar.
Both GranuFlo and NaturaLyte were produced by Fresenius for hemodialysis centers across the entire United States.
Contact the office of Frank Charles Miranda, P.A. at 813-254-2637 to discuss your experience with Fresenius products during kidney dialysis treatments.